Pfizer Inc. and GlaxoSmithKline have entered into an agreement to create a global consumer healthcare company with their iconic brands. Pfizer will contribute its consumer healthcare business to GlaxoSmithKline’s existing consumer healthcare business. The 2017 global sales for the combined business were approximately $12.7 billion.  Pfizer will receive a 32% equity stake in the joint venture, entitling Pfizer to share the joint venture’s earnings and dividends. Pfizer will have the right to a...